接受治疗的慢性高血压孕妇心室肥厚的发生频率及后果
本研究回顾性分析2009年1月至2015年2月在本院分娩并接受降压治疗的慢性高血压孕妇,所有患者均行母体超声心动图。253例中48例(19%)符合左心室肥厚标准,左心室肥厚组早产、叠加子痫前期及新生儿需重症监护的风险显著更高,调整年龄、种族和产次后仍持续。
要点
- 慢性高血压孕妇中约1/5存在左心室肥厚。
- 左心室肥厚组早产、叠加子痫前期及新生儿重症监护风险更高。
- 随心室质量增加,早产严重程度显著增加。
核心结论
- 接受产前治疗的慢性高血压孕妇中,每5例有1例存在左心室肥厚。
- 左心室肥厚孕妇发生叠加子痫前期及其围产期早产后遗症的风险显著更高。
研究设计与样本
- 回顾性研究,纳入2009年1月至2015年2月在本院分娩的慢性高血压孕妇,所有接受降压治疗者均行母体超声心动图并在专门的高危产前门诊管理。
- 左心室肥厚采用美国超声心动图学会标准定义:左心室质量指数>95 g/m2。
- 共253例孕妇接受超声心动图检查,其中48例(19%)符合左心室肥厚标准。
主要发现
- 左心室肥厚组与非左心室肥厚组相比,非裔美国人比例显著更高(P = .031),其他人口学特征无差异。
- 整个队列超过85%的孕妇体重指数>30 kg/m2,三分之一孕妇为III度肥胖(体重指数>40 kg/m2)。
- 两组慢性高血压病程(P = .248)和超声心动图检查时孕周(P = .316)无显著差异,左心室射血分数保留(P = .303)。
- 左心室肥厚组与非左心室肥厚组相比,早产风险更高(P = .001)、叠加子痫前期风险更高(P = .028)、婴儿需重症监护风险更高(P = .023),调整年龄、种族和产次后这些发现持续存在。
- 根据超声测量的左心室大小分析分娩孕周,随着心室质量增加,与早产严重程度显著相关(P < .001)。
关键数值与推荐
- 左心室肥厚定义:左心室质量指数>95 g/m2(美国超声心动图学会标准)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ventricular hypertrophy is a known sequela of long-standing chronic hypertension with associated morbidity and mortality. OBJECTIVE: We sought to assess the frequency and importance of left ventricular hypertrophy in gravidas treated for chronic hypertension during pregnancy. STUDY DESIGN: This was a retrospective study of pregnant women with chronic hypertension who were delivered at our hospital from January 2009 through February 2015. All women who were given antihypertensive therapy underwent maternal echocardiography and were managed in a dedicated, high-risk prenatal clinic. Left ventricular hypertrophy was defined using the criteria of the American Society of Echocardiography as left ventricular mass indexed to maternal body surface area with a value of >95 g/m2. Maternal and infant outcomes were then analyzed according to the presence or absence of left ventricular hypertrophy. RESULTS: Of 253 women who underwent echocardiography, 48 (19%) met criteria for left ventricular hypertrophy. Women in this latter cohort were significantly more likely to be African American (P = .031), but there were no other demographic differences. More than 85% of the entire cohort had a body mass index >30 kg/m2 and a third of all women had class III obesity with a body mass index of >40 kg/m2. Importantly, duration of chronic hypertension (P = .248) and gestational age at time of echocardiography (P = .316) did not differ significantly between the groups. Left ventricular function was preserved in both groups as measured by left ventricular ejection fraction (P = .303). Those with ventricular hypertrophy were at greater risk to be delivered preterm (P = .001), to develop superimposed preeclampsia (P = .028), and to have an infant requiring intensive care (P = .023) when compared with women without ventricular hypertrophy. These findings persisted after adjustment for age, race, and parity. The gestational age at delivery according to measured left ventricular size was also examined and with increasing ventricular mass there was a significant association with the severity of preterm birth (P < .001). CONCLUSION: Left ventricular hypertrophy was identified in 1 in 5 women given antepartum treatment for chronic hypertension. Further analysis showed that these women were at significantly greater risk for superimposed preeclampsia and its attendant perinatal sequelae of preterm birth.
引用
- Ambia AM, Morgan JL, Wilson KL, et al. Frequency and consequences of ventricular hypertrophy in pregnant women with treated chronic hypertension. Am J Obstet Gynecol. 2017. PMID: 28602773. doi:10.1016/j.ajog.2017.05.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。